Toronto, Ontario–(Newsfile Corp. – May 18, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that through its telehealth business, Medi-Call Inc., it will begin to service live telehealth patient requests via the mobile application commencing Tuesday, May 24, 2022. Bringing the Medi-Call telemedicine services to real clients for the first time will be a big milestone for the Company as it enters into this second rollout phase of the application launch.
“We are excited with the progress we’ve made with Medi-Call and cannot wait to begin bringing it to more patients in need of direct healthcare, both in person and through telemedicine,” said Omar Sharif, President of Medi-Call.
To view an enhanced version of this graphic, please visit:
The Medi-Call app will help physicians effectively manage their appointments, while simultaneously providing faster treatment and care for patients. At a time when digital access to healthcare is more important than ever with increasing hospital wait times, data shows that more people are turning to telehealth for medical care and treatment – only further amplified by the pandemic.
- Medi-Call is a subscription-based software as a service (SaaS) mobile app that connects patients with doctors. It is an integrated grid system that connects patients with providers in real time.
- Solving accessibility issues for patients living in rural or isolated communities and those also have limited mobility
- Improving coordination and communication of treatment among healthcare team members and their patients
- Facilitating mobile health care services including prescriptions
Visit Medicallmd.ca to learn more about Medi-Call.
The Company announces a change to its Board of Directors effective May 17, 2022, with Mr. Andrew Ryu stepping down for personal reasons as Director and Executive Chairman, and director Mr. Paul Haber has been appointed as Chairman. The Company would like to thank Mr. Ryu for his direct contribution to the success of the Company, resulting in record profits year-over-year (YoY).
“Andrew helped us steer the ship during a time where Datametrex really needed a turnaround. We are very grateful for his contributions and continued support,” said Marshall Gunter, CEO of the Company.
Datametrex AI Limited is a technology-focused company with using artificial intelligence (AI) to create progressive solutions for the cyber security, telehealth, and electric vehicle (EV) verticals. Datametrex’ mission is to provide tools that support companies in fulfilling their operational goals with predictive and preventive technologies.
For additional information on Datametrex and other corporate information, please visit the Company’s website at www.datametrex.com.
For further information:
Investor Relations & Communications
Kristina Colpitts, Director
Email: [email protected]
Telephone: 416-901-5611 x 204
Marshall Gunter- CEO
Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company’s control. In particular, there is no guarantee that the parties will successfully negotiate and enter into a definitive agreement on mutually acceptable terms or complete the Transaction in the manner contemplated herein, if at all, that the due diligence of any of the parties will be satisfactory, or that the parties will obtain any required board, shareholder, third-party and/or regulatory or other governmental approvals, if any. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/124381